These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17342498)

  • 1. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid.
    Oderda G; Asche C; Jones KP; Merrill RM; Spalding J
    Arch Gynecol Obstet; 2007 Sep; 276(3):211-8. PubMed ID: 17342498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
    Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
    J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
    Goldberg J; Bussard A; McNeil J; Diamond J
    Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
    Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
    J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
    Beinfeld MT; Bosch JL; Isaacson KB; Gazelle GS
    Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic impact of uterine fibroids in the United States: a summary of published estimates.
    Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
    J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
    Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
    J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization costs associated with leiomyoma.
    Zhao SZ; Wong JM; Arguelles LM
    Clin Ther; 1999 Mar; 21(3):563-75. PubMed ID: 10321423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study.
    Wu O; Briggs A; Dutton S; Hirst A; Maresh M; Nicholson A; McPherson K
    BJOG; 2007 Nov; 114(11):1352-62. PubMed ID: 17949377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
    Coyne KS; Margolis MK; Murphy J; Spies J
    Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
    Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
    BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care resource use for uterine fibroid tumors in the United States.
    Flynn M; Jamison M; Datta S; Myers E
    Am J Obstet Gynecol; 2006 Oct; 195(4):955-64. PubMed ID: 16723104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the total costs of surgical treatment for uterine fibroids?
    Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
    J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and socioeconomic impact of uterine fibroids.
    Greenberg MD; Kazamel TI
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):625-36. PubMed ID: 8786874
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy.
    Istre O
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):735-47. PubMed ID: 18328788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual costs associated with diagnosis of uterine leiomyomata.
    Hartmann KE; Birnbaum H; Ben-Hamadi R; Wu EQ; Farrell MH; Spalding J; Stang P
    Obstet Gynecol; 2006 Oct; 108(4):930-7. PubMed ID: 17012456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma.
    Jacobson GF; Shaber RE; Armstrong MA; Hung YY
    Am J Obstet Gynecol; 2007 Jun; 196(6):601.e1-5; discussion 601.e5-6. PubMed ID: 17547914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary management of uterine fibroids: focus on emerging medical treatments.
    Singh SS; Belland L
    Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.